S. Julius, Amlodipine in hypertension: an overview of the clinical dossier., in J Cardiovasc Pharmacol, 12 Suppl 7, 1988, pp. S27-33, PMID2467123.
J. Luksa, D. Josic; M. Kremser; Z. Kopitar; S. Milutinovic, Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration., in J Chromatogr B Biomed Sci Appl, vol. 703, n. 1-2, Dec 1997, pp. 185-93, PMID9448075.
PA. van Zwieten, Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties., in Clin Cardiol, vol. 17, 9 Suppl 3, Sep 1994, pp. III3-6, PMID9156957.
D. Murdoch, RC. Heel, Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease., in Drugs, vol. 41, n. 3, Mar 1991, pp. 478-505, PMID1711448.
LH. Opie, Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine., in Postgrad Med J, 67 Suppl 5, 1991, pp. S2-8, PMID1666430.
RA. Burges, The pharmacological profile of amlodipine in relation to ischaemic heart disease., in Postgrad Med J, 67 Suppl 3, 1991, pp. S9-15, PMID1836872.
IH. Osterloh, An update on the safety of amlodipine., in J Cardiovasc Pharmacol, 17 Suppl 1, 1991, pp. S65-8, PMID16296714.
RA. Burges, MG. Dodd; DG. Gardiner, Pharmacologic profile of amlodipine., in Am J Cardiol, vol. 64, n. 17, Nov 1989, pp. 10I-18I; discussion 18I-20I, PMID2554708.
RA. Burges, Amlodipine: a once daily calcium antagonist., in J Hum Hypertens, 5 Suppl 1, Aug 1991, pp. 49-54, PMID1834846.
T. Tejada, A. Fornoni; O. Lenz; BJ. Materson, Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?, in Curr Hypertens Rep, vol. 9, n. 4, Aug 2007, pp. 284-90, PMID17686378.
PA. Meredith, HL. Elliott, Clinical pharmacokinetics of amlodipine., in Clin Pharmacokinet, vol. 22, n. 1, Jan 1992, pp. 22-31, PMID1532771.
DM. Williams, LX. Cubeddu, Amlodipine pharmacokinetics in healthy volunteers., in J Clin Pharmacol, vol. 28, n. 11, Nov 1988, pp. 990-4, PMID2977393.
DA. Stopher, AP. Beresford; PV. Macrae; MJ. Humphrey, The metabolism and pharmacokinetics of amlodipine in humans and animals., in J Cardiovasc Pharmacol, 12 Suppl 7, 1988, pp. S55-9, PMID2467130.
DR. Abernethy, The pharmacokinetic profile of amlodipine., in Am Heart J, vol. 118, 5 Pt 2, Nov 1989, pp. 1100-3, PMID2530866.
DR. Abernethy, Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist., in J Cardiovasc Pharmacol, 17 Suppl 1, 1991, pp. S4-7, PMID16296697.
FP. Cappuccio, ND. Markandu; DR. Singer; GA. MacGregor, Amlodipine and lisinopril in combination for the treatment of essential hypertension: efficacy and predictors of response., in J Hypertens, vol. 11, n. 8, Aug 1993, pp. 839-47, PMID8228208.
E. Juncadella García, JM. Fandos Olona; J. Alba Granados; R. Descarrega Queralt, [Gingival hyperplasia induced by amlodipine]., in Med Clin (Barc), vol. 103, n. 9, Sep 1994, pp. 358-9, PMID7967902.
P. Infante Cossío, J. Torelló Iserte; F. Espín Gálvez; A. García-Perla; L. Rodríguez-Armijo Sánchez; JR. Castillo Ferrando, [Gingival hyperplasia associated with amlodipine]., in An Med Interna, vol. 14, n. 2, Feb 1997, pp. 83-5, PMID9206519.
A. Lafzi, RM. Farahani; MA. Shoja, Amlodipine-induced gingival hyperplasia., in Med Oral Patol Oral Cir Bucal, vol. 11, n. 6, pp. E480-2, PMID17072250.
I. Osterloh, The safety of amlodipine., in Am Heart J, vol. 118, 5 Pt 2, Nov 1989, pp. 1114-9; discussion 1119-20, PMID2573265.
ED. Dunlap, JS. Plowden; DA. Lathrop; RW. Millard, Hemodynamic and electrophysiologic effects of amlodipine, a new calcium channel blocker., in Am J Cardiol, vol. 64, n. 17, Nov 1989, pp. 71I-77I, PMID2530888.